| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |